# FDA Inspection 1309232 - Agupunt USA Corp - March 25, 2026

Source: https://www.keypedia.com/records/fda_inspections/agupunt-usa-corp/0343619c-6db0-4ecb-91a2-15b93ddb5ea9
Source feed: FDA_Inspections

> FDA Inspection 1309232 for Agupunt USA Corp on March 25, 2026. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1309232
- Company Name: Agupunt USA Corp
- Inspection Date: 2026-03-25
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Compliance: Medical Devices
- Product Type: Medical Devices & Rad Health
- Office Name: Florida District Office

## Related Documents

- [FDA Inspection 1309232 - 2026-03-25](https://www.keypedia.com/records/fda_inspections/agupunt-usa-corp/aad053e1-91e0-4ea9-ac05-38f52f22ec8e)
- [FDA Inspection 1309232 - 2026-03-25](https://www.keypedia.com/records/fda_inspections/agupunt-usa-corp/7a7b1b63-5243-4766-b974-6a9699ce9813)
- [FDA Inspection 1309232 - 2026-03-25](https://www.keypedia.com/records/fda_inspections/agupunt-usa-corp/cad5c028-1c21-4a31-8c17-db7e14d276fb)

Company: https://www.keypedia.com/companies/agupunt-usa-corp/3f9fb8a1-a2d8-4f50-a1e0-14019ac4e922

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9